Biocept Inc (BIOC) - Product Pipeline Analysis, 2019 Update

Biocept Inc (BIOC) - Product Pipeline Analysis, 2019 Update

Summary

Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biocept Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biocept Inc Company Overview
Biocept Inc Company Snapshot
Biocept Inc Pipeline Products and Ongoing Clinical Trials Overview
Biocept Inc – Pipeline Analysis Overview
Biocept Inc - Key Facts
Biocept Inc - Major Products and Services
Biocept Inc Pipeline Products by Development Stage
Biocept Inc Ongoing Clinical Trials by Trial Status
Biocept Inc Pipeline Products Overview
Companion Diagnostic Target Selector Test - SCLC
Companion Diagnostic Target Selector Test - SCLC Product Overview
MicroRNA Test - Lung Cancer
MicroRNA Test - Lung Cancer Product Overview
OncoCEE - CR (FISH)
OncoCEE - CR (FISH) Product Overview
preCEED
preCEED Product Overview
Target Selector CTC Test - ESR1
Target Selector CTC Test - ESR1 Product Overview
Target Selector CTC Test - ESR1 Clinical Trial
Target Selector CTC Test - PTEN Deletion
Target Selector CTC Test - PTEN Deletion Product Overview
Target Selector ctDNA Test - ALK
Target Selector ctDNA Test - ALK Product Overview
Target Selector ctDNA Test - ALK Clinical Trial
Target Selector ctDNA Test - ESR1
Target Selector ctDNA Test - ESR1 Product Overview
Biocept Inc - Key Competitors
Biocept Inc - Key Employees
Biocept Inc - Locations And Subsidiaries
Head Office
Recent Developments
Biocept Inc, Recent Developments
Aug 12, 2019: Biocept reports second quarter 2019 financial results
Jun 18, 2019: Biocept announces commercial launch of Target Selector NGS Breast Panel, the Company's Second Multi-Gene Tumor-Specific Panel
May 28, 2019: Biocept awarded patent in china for its circulating tumor cell platform expanding intellectual property estate to 33 issued patents globally
May 20, 2019: Biocept introduces liquid biopsy panel for lung cancer
May 08, 2019: Biocept reports first quarter 2019 financial results
Mar 28, 2019: Biocept reports 2018 fourth quarter and full year financial results
Mar 26, 2019: Biocept broadens commercial focus of its target selector liquid biopsy platform to include urology market segment
Mar 18, 2019: Biocept awarded patent in Japan for the capture of rare cells including CTCs from any biological sample of interest with a microchannel device
Mar 13, 2019: Biocept expands its pathology partnership offering for liquid biopsy with the addition of several key services
Mar 04, 2019: Biocept's liquid biopsy test for ESR1 biomarker detection to be featured in poster presentation at the 2019 AACR Annual Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Biocept Inc Pipeline Products and Ongoing Clinical Trials Overview
Biocept Inc Pipeline Products by Equipment Type
Biocept Inc Pipeline Products by Indication
Biocept Inc Ongoing Clinical Trials by Trial Status
Biocept Inc, Key Facts
Biocept Inc, Major Products and Services
Biocept Inc Number of Pipeline Products by Development Stage
Biocept Inc Pipeline Products Summary by Development Stage
Biocept Inc Ongoing Clinical Trials by Trial Status
Biocept Inc Ongoing Clinical Trials Summary
Companion Diagnostic Target Selector Test - SCLC - Product Status
Companion Diagnostic Target Selector Test - SCLC - Product Description
MicroRNA Test - Lung Cancer - Product Status
MicroRNA Test - Lung Cancer - Product Description
OncoCEE - CR (FISH) - Product Status
OncoCEE - CR (FISH) - Product Description
preCEED - Product Status
preCEED - Product Description
Target Selector CTC Test - ESR1 - Product Status
Target Selector CTC Test - ESR1 - Product Description
Target Selector CTC Test - ESR1 - Biocept's Liquid Biopsy Platform to Evaluate Cerebrospinal Fluid of Breast Cancer Patients for Metastatic Biomarkers
Target Selector CTC Test - PTEN Deletion - Product Status
Target Selector CTC Test - PTEN Deletion - Product Description
Target Selector ctDNA Test - ALK - Product Status
Target Selector ctDNA Test - ALK - Product Description
Target Selector ctDNA Test - ALK - Evaluation of Liquid Biopsies in Localized and Advanced Lung Cancer Patients
Target Selector ctDNA Test - ESR1 - Product Status
Target Selector ctDNA Test - ESR1 - Product Description
Biocept Inc, Key Employees
Glossary
List of Figures
Biocept Inc Pipeline Products by Equipment Type
Biocept Inc Pipeline Products by Development Stage
Biocept Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook